USPTO serial 98377787
OSTEOVET
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- HACK, ANDREA R
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with OSTEOVET?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Frederick, MD, US
Frederick, MD, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Aaron D. Hendelman
Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI650 Page Mill RoadPalo Alto, CA 94304United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | therapeutic proteins for veterinary medical use in vascular repair, orthopedic repair, bone repair, dental repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, craniomaxillofacial repair, trauma repair, immuno-oncology, orthopedic oncology, and chemotherapeutics; veterinary pharmaceutical and medicinal preparations and substances, namely, therapeutic proteins for veterinary medical purposes used for vascular repair, orthopedic repair, bone repair, dental repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, craniomaxillofacial repair, trauma repair, immuno-oncology, orthopedic oncology, and chemotherapeutics | ACTIVE | — |
| 042 | research and development in connection with protein therapies for use in pharmaceutical products, orthopedic oncology, and immuno-oncology for veterinary medical purposes; veterinary medical research and product development in the fields of biotechnology, drug discovery, pharmaceuticals, scientific research, orthopedic oncology, immuno-oncology and protein therapeutics; development of therapeutics for veterinary purposes, namely, pharmaceutical and medical therapies for use in vascular repair, orthopedic repair, bone repair, dental repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, craniomaxillofacial repair, trauma repair, orthopedic oncology, immuno-oncology and chemotherapeutics; veterinary scientific research and development | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 29, 2026 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 29, 2026 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 8, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 7, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Nov 7, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Nov 7, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 6, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| May 8, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 7, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| May 7, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| May 7, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 26, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 6, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 6, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 6, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 1, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 1, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 11, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 29, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 22, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 31, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 26, 2024 | NWAP | NEW APPLICATION ENTERED | — |